EMEA-001645-PIP01-14-M03

Key facts

Invented name
Zinplava
Active substance
bezlotoxumab
Therapeutic area
Infectious diseases
Decision number
P/0104/2020
PIP number
EMEA-001645-PIP01-14-M03
Pharmaceutical form(s)
Concentrate for solution for infusion
Condition(s) / indication(s)
Prevention of recurrence of Clostridioides difficile infection
Route(s) of administration
Intravenous use
Contact for public enquiries
Merck Sharp & Dohme (Europe), Inc.

Tel. +33 180464738
E-mail: pip.information@merck.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating